vs

Side-by-side financial comparison of AMERISAFE INC (AMSF) and Cryoport, Inc. (CYRX). Click either name above to swap in a different company.

AMERISAFE INC is the larger business by last-quarter revenue ($80.1M vs $45.5M, roughly 1.8× Cryoport, Inc.). AMERISAFE INC runs the higher net margin — 10.2% vs -17.5%, a 27.7% gap on every dollar of revenue. On growth, AMERISAFE INC posted the faster year-over-year revenue change (10.3% vs 9.6%). Over the past eight quarters, Cryoport, Inc.'s revenue compounded faster (10.4% CAGR vs 2.8%).

AMERISAFE Inc. is a specialty insurance provider that focuses exclusively on workers' compensation coverage for small and mid-sized businesses in high-hazard industries including construction, logging, trucking, and manufacturing. It operates across 49 U.S. states, offering tailored insurance policies paired with targeted risk management support for clients.

Cryoport, Inc. is a global provider of specialized temperature-controlled logistics and supply chain solutions focused on the life sciences, biopharmaceutical, and cell and gene therapy sectors. It partners with research institutions, biotech firms, and pharmaceutical manufacturers globally to support the safe transport of sensitive biological materials including clinical trial samples and advanced therapy products.

AMSF vs CYRX — Head-to-Head

Bigger by revenue
AMSF
AMSF
1.8× larger
AMSF
$80.1M
$45.5M
CYRX
Growing faster (revenue YoY)
AMSF
AMSF
+0.7% gap
AMSF
10.3%
9.6%
CYRX
Higher net margin
AMSF
AMSF
27.7% more per $
AMSF
10.2%
-17.5%
CYRX
Faster 2-yr revenue CAGR
CYRX
CYRX
Annualised
CYRX
10.4%
2.8%
AMSF

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMSF
AMSF
CYRX
CYRX
Revenue
$80.1M
$45.5M
Net Profit
$8.1M
$-8.0M
Gross Margin
47.8%
Operating Margin
-17.0%
Net Margin
10.2%
-17.5%
Revenue YoY
10.3%
9.6%
Net Profit YoY
-9.0%
57.4%
EPS (diluted)
$0.43
$-0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMSF
AMSF
CYRX
CYRX
Q1 26
$80.1M
Q4 25
$81.6M
$45.5M
Q3 25
$82.0M
$44.2M
Q2 25
$81.1M
$45.5M
Q1 25
$72.6M
$41.0M
Q4 24
$74.0M
$41.5M
Q3 24
$78.7M
$38.3M
Q2 24
$75.8M
$39.7M
Net Profit
AMSF
AMSF
CYRX
CYRX
Q1 26
$8.1M
Q4 25
$10.4M
$-8.0M
Q3 25
$13.8M
$-6.9M
Q2 25
$14.0M
$105.2M
Q1 25
$8.9M
$-12.0M
Q4 24
$13.2M
$-18.7M
Q3 24
$14.3M
$805.0K
Q2 24
$11.0M
$-78.0M
Gross Margin
AMSF
AMSF
CYRX
CYRX
Q1 26
Q4 25
47.8%
Q3 25
48.2%
Q2 25
47.0%
Q1 25
45.4%
Q4 24
47.0%
Q3 24
45.5%
Q2 24
44.5%
Operating Margin
AMSF
AMSF
CYRX
CYRX
Q1 26
Q4 25
15.6%
-17.0%
Q3 25
21.3%
-22.5%
Q2 25
21.5%
-21.2%
Q1 25
15.5%
-23.1%
Q4 24
22.7%
-30.7%
Q3 24
22.6%
-34.9%
Q2 24
18.1%
-196.5%
Net Margin
AMSF
AMSF
CYRX
CYRX
Q1 26
10.2%
Q4 25
12.8%
-17.5%
Q3 25
16.9%
-15.7%
Q2 25
17.2%
231.4%
Q1 25
12.3%
-29.2%
Q4 24
17.8%
-45.1%
Q3 24
18.2%
2.1%
Q2 24
14.5%
-196.4%
EPS (diluted)
AMSF
AMSF
CYRX
CYRX
Q1 26
$0.43
Q4 25
$0.55
$-0.19
Q3 25
$0.72
$-0.18
Q2 25
$0.73
$2.05
Q1 25
$0.47
$-0.28
Q4 24
$0.69
$-0.42
Q3 24
$0.75
$-0.02
Q2 24
$0.57
$-1.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMSF
AMSF
CYRX
CYRX
Cash + ST InvestmentsLiquidity on hand
$34.2M
$411.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$246.6M
$502.6M
Total Assets
$765.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMSF
AMSF
CYRX
CYRX
Q1 26
$34.2M
Q4 25
$61.9M
$411.2M
Q3 25
$54.7M
$421.3M
Q2 25
$48.5M
$426.0M
Q1 25
$44.8M
$244.0M
Q4 24
$44.1M
$250.6M
Q3 24
$63.7M
$259.4M
Q2 24
$30.6M
$414.9M
Stockholders' Equity
AMSF
AMSF
CYRX
CYRX
Q1 26
$246.6M
Q4 25
$251.6M
$502.6M
Q3 25
$274.8M
$513.3M
Q2 25
$265.6M
$519.1M
Q1 25
$260.8M
$398.8M
Q4 24
$257.3M
$401.9M
Q3 24
$314.4M
$418.6M
Q2 24
$301.0M
$400.1M
Total Assets
AMSF
AMSF
CYRX
CYRX
Q1 26
Q4 25
$1.1B
$765.0M
Q3 25
$1.2B
$774.3M
Q2 25
$1.2B
$773.9M
Q1 25
$1.2B
$699.8M
Q4 24
$1.2B
$703.5M
Q3 24
$1.3B
$701.8M
Q2 24
$1.2B
$852.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMSF
AMSF
CYRX
CYRX
Operating Cash FlowLast quarter
$919.0K
Free Cash FlowOCF − Capex
$-4.5M
FCF MarginFCF / Revenue
-10.0%
Capex IntensityCapex / Revenue
12.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-25.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMSF
AMSF
CYRX
CYRX
Q1 26
Q4 25
$11.1M
$919.0K
Q3 25
$10.7M
$2.2M
Q2 25
$-8.4M
$-7.3M
Q1 25
$-1.8M
$-4.3M
Q4 24
$24.2M
$-5.5M
Q3 24
$8.4M
$447.0K
Q2 24
$-2.6M
$-8.0M
Free Cash Flow
AMSF
AMSF
CYRX
CYRX
Q1 26
Q4 25
$8.9M
$-4.5M
Q3 25
$9.8M
$-1.3M
Q2 25
$-9.5M
$-11.7M
Q1 25
$-1.8M
$-7.5M
Q4 24
$23.4M
$-10.7M
Q3 24
$8.4M
$-3.8M
Q2 24
$-2.6M
$-11.8M
FCF Margin
AMSF
AMSF
CYRX
CYRX
Q1 26
Q4 25
10.9%
-10.0%
Q3 25
11.9%
-2.9%
Q2 25
-11.7%
-25.7%
Q1 25
-2.5%
-18.3%
Q4 24
31.5%
-25.8%
Q3 24
10.7%
-9.9%
Q2 24
-3.5%
-29.8%
Capex Intensity
AMSF
AMSF
CYRX
CYRX
Q1 26
Q4 25
2.6%
12.0%
Q3 25
1.1%
7.8%
Q2 25
1.3%
9.6%
Q1 25
0.0%
7.7%
Q4 24
1.1%
12.6%
Q3 24
0.0%
11.1%
Q2 24
0.1%
9.5%
Cash Conversion
AMSF
AMSF
CYRX
CYRX
Q1 26
Q4 25
1.06×
Q3 25
0.77×
Q2 25
-0.61×
-0.07×
Q1 25
-0.20×
Q4 24
1.83×
Q3 24
0.59×
0.56×
Q2 24
-0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons